HCMT
OPNT

Highland Capital Management (Texas)’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Highland Capital Management (Texas)’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12,800
Closed -$471K – 352
2017
Q3 		$471K Buy
+12,800
New +$477K 0.02% 228

Other funds holding OPNT

VCM
Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tradewinds Capital Management Bellingham, Washington $563M AUM 41.52% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return

Highland Capital Management (Texas)'s OPNT Position: Q4 2017 in Review

Highland Capital Management (Texas) sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q4 2017, closing a stake of 12,800 shares — an estimated $471K sold.

Highland Capital Management (Texas) first reported a position in OPNT in Q3 2017 and held it in 1 quarter. The position peaked at $471K in Q3 2017. 16 funds tracked by Wall St. Rank hold OPNT as of Q4 2017.

  • Highland Capital Management (Texas) reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 12,800 Opiant Pharmaceuticals, Inc. Common Stock shares in Q4 2017, an estimated $471K.
  • Highland Capital Management (Texas) first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • Highland Capital Management (Texas)'s Opiant Pharmaceuticals, Inc. Common Stock position peaked at $471K in Q3 2017.
  • 16 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q4 2017.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2017, filed 14 Feb 2018.